Summary
Epilepsy is a common disorder and requires long-term drug treatment. Epileptics on anticonvulsant therapy have often been reported to have a depressed immune system, especially an IgA deficiency. An association with clinical manifestations has not yet been clearly explored. So far investigations have been performed in Whites only. The objectives of this study were to assess if there is a racial difference in the immune response to anticonvulsants between Blacks and Whites and to establish the clinical significance of the IgA deficiency. Our results showed normal IgA values in Black and White epileptics on anticonvulsant therapy. This implies, at least at the present stage, that patients do not require immunological monitoring or protective measurements. Further studies including the determination of secretory IgA might help to explain the discrepancy between our findings and the literature and should provide deeper insight into the correlation between potential immune disturbances and clinical implications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tomasi TB, Grey HM (1972) Structure and function of immunoglobulin. A. Progr Allergy 16: 81–213
Østergaard PA (1980) Clinical and immunological features of transient IgA deficiency in children. Clin Exp Immunol 40: 561–565
Walker WA (1981) Antigen uptake in the gut: Immunologic implications. Immunol Today. 2: 30–34
Winkelstein A (1980) Immune deficiency disorders. Sandorama 3: 29–32
Burgio GR, Duse M, Monafo V et al. (1980) Selective IgA deficiency: Clinical and immunological evaluation of 50 paediatric patients. Eur J Paediatr 133: 101–106
Aarli JA (1976) Drug-induced IgA deficiency in epileptic patients. Arch Neurol 33: 296–299
Siegel S (1956) Nonparametric statistics. McGraw-Hill, New York Toronto London
Grob PJ, Herold GE (1972) Immunological abnormalities and hydantoins. Brit Med J 2: 561–563
Joubert PH, Aucamp AK, Potgieter GM et al. (1977) Epilepsy and IgA deficiency — the effect of sodium valproate. S Afr Med J 52: 642–644
Seager J, Jamison DL, Wilson J et al. (1975) IgA deficiency, epilepsy and phenytoin treatment. Lancet 2: 632–635
Haldorsen T, Aarli JA (1977) Immunoglobulin concentrations in first-degree relatives of epileptic patients with drug-induced IgA deficiency. Acta Neurol Scand 56: 608–612
Salus (1982) Misverstande oor epilepsie is onnodig. South African Department of Health, Welfare and Pensions, Pretoria, pp6
Eadie MJ (1981) Anticonvulsant therapy: Present and future. TIPS 2: 37–39
Holborow J, Lessof M (1981) Immune mechanisms in health and disease. Med Int 1: 213–220
Doe W (1982) Immunology of the gastrointestinal tract. Med Int 12: 550–554
Russell MW, Brown TA, Mestecky J (1981) Role of serum IgA. J Exp Med 153: 968–976
Roode H (1977) 'n Ondersoek na die serumimmunoglobulienwaardes by gesonde jong blanke en bantukinders en kinders met lugweg infeksies. M.D. Thesis, University of Pretoria, South Africa
Anderson P, Mosekilde L (1977) Immunoglobulin levels and autoantibodies in epileptics on long-term anticonvulsant therapy. Acta Med Scand 201: 69–74
Gilhus NE, Matre R, Aarli JA (1982) Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. Int J Immunopharmacol 4: 43–48
Fontana A, Grob PJ, Sauter R et al. (1976) IgA deficiency, epilepsy and hydantoin medication. Lancet 2: 228–231
Gilhus NE, Aarli JA (1981) Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients. Acta Neurol Scand 63: 34–43
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meissner, O., Joubert, H.F., Joubert, P.H. et al. IgA in epileptics receiving anticonvulsant therapy. Eur J Clin Pharmacol 25, 491–495 (1983). https://doi.org/10.1007/BF00542116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542116